While the majority of the adults infected with hepatitis C virus are baby boomers-people between the ages of 51 and 71 years-Alaska is seeing a large spike in infection rates among young adults.
While the majority of the adults infected with hepatitis C virus (HCV) are baby boomers—people between the ages of 51 and 71 years—Alaska is seeing a large spike in infection rates among young adults.
A bulletin published by the State of Alaska Section of Epidemiology reported that there have been large increases of HCV infection rates among 18- to 29-year-olds. The largest reported change was an increase of 490% from 2011 to 2015 in southeastern Alaska. The gulf coast region of Alaska had the smallest change, but still reported an increase of 45%.
According to the bulletin, injection drug use (IDU) among young adults is likely the cause of the rising number of HCV-infected individuals between the ages of 18 and 29.
“Previous Alaska data on HCV prevalence demonstrated the majority of HCV cases reported were among ‘baby boomers,’” the authors of the report wrote. “The recent increase in HCV among young adults follows national HCV trends and we presume that our HCV-infected young adults share similar IDU risk factors.”
Although the number of reported HCV cases rose considerably across all age groups from 2011 to 2015 in Alaska, the increase was proportionally highest among young adults. In 2011, young adults represented 22% of all newly reported HCV cases, but in 2015, they represented 31% of new cases.
In addition, the Section of Epidemiology found that while most cases of new HCV infection across all age groups were in males, among young adults, females represented the most cases of new HCV infection.
The report noted that one of the ways to decrease IDU, and HCV infection, is through the use of syringe exchange programs.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More